Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV001074682 | SCV000281864 | pathogenic | Retinal dystrophy | 2020-01-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000478178 | SCV000564528 | pathogenic | not provided | 2023-03-24 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 10958763, 11702214, 17982420, 28559085, 29925512, 19265867, 30060493, 29178665, 19074458, 34426522, 31589614, 35119454, 32531858, 32619608, Saleh2021[noPMID]) |
Blueprint Genetics | RCV001074682 | SCV001240275 | pathogenic | Retinal dystrophy | 2019-03-21 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV001196593 | SCV001367201 | likely pathogenic | Age related macular degeneration 2 | 2020-02-04 | criteria provided, single submitter | clinical testing | This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PM1,PM2,PP3. |
Ce |
RCV000478178 | SCV001501909 | likely pathogenic | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | ABCA4: PM1, PM2, PP1, PP3 |
Labcorp Genetics |
RCV000478178 | SCV001585366 | pathogenic | not provided | 2024-12-30 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1098 of the ABCA4 protein (p.Arg1098Cys). This variant is present in population databases (rs756840095, gnomAD 0.006%). This missense change has been observed in individual(s) with Stargardt disease or cone rod distrophy (PMID: 19074458, 23096905, 28559085, 29925512). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 236100). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Juno Genomics, |
RCV004796121 | SCV005418273 | pathogenic | Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 | criteria provided, single submitter | clinical testing | PM2_Supporting+PP3_Moderate+PM3_VeryStrong | |
Ophthalmo- |
RCV000408518 | SCV005046999 | pathogenic | Severe early-childhood-onset retinal dystrophy | no assertion criteria provided | research |